首页>Basic & clinical pharmacology & toxicology.>Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV HIV ‐infected Patients: Efficacy, Safety and Tolerance
Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV HIV ‐infected Patients: Efficacy, Safety and Tolerance
作者单位:Division of Clinical VirologyUniversity of A Coru?a (UDC)A Coru?a,Spain[1]Clinical Epidemiology and Biostatistics UnitUniversity of A Coru?a (UDC)A Coru?a,Spain[2]Infectious Diseases Service and ‘Fight AIDS’ FoundationHospital Universitari Germans Trias i[3]Service of PharmacySERGASA Coru?a,Spain[4]